S
Saravanan
About Saravanan
Data last updated:
Saravanan is a Director at Maxell Pharma Private Limited (since 2010). The company operates in Pharma. Maxell Pharma Private Limited reported revenue of ₹6.92 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maxell Pharma Private Limited U24297TN2010PTC075380 | Director | 16 Apr 2010 | 2010 | ₹6.92 Cr (FY 2024) | Active |
Board colleagues of Saravanan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gnanasekaran Satheeshkumar | 02972414 | Maxell Pharma Private Limited | Director |
| Madhuram Senthil Kumar | 09066311 | Maxell Pharma Private Limited | Director |
| Madhuram Udhaya Chander | 02997703 | Maxell Pharma Private Limited | Director |
| Shankar Subramanian | 03015878 | Maxell Pharma Private Limited | Managing Director |
| Takai Ali Bayas Ali | 02999098 | Maxell Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saravanan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saravanan
Saravanan currently holds 1 directorship: Maxell Pharma Private Limited (Director, since 16 Apr 2010, revenue ₹6.92 Cr (FY 2024)).
Saravanan was first appointed on 16 Apr 2010 as Director at Maxell Pharma Private Limited.
The current boards of Saravanan's companies include Gnanasekaran Satheeshkumar (Maxell Pharma Private Limited), Madhuram Senthil Kumar (Maxell Pharma Private Limited), Madhuram Udhaya Chander (Maxell Pharma Private Limited), Shankar Subramanian (Maxell Pharma Private Limited), Takai Ali Bayas Ali (Maxell Pharma Private Limited).